Development of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale, associated with nanoparticles adjuvants.
Development of recombinant vaccine against tick fever disease based on chimeric protein of Babesia sp and Anaplasma marginale, associated with nanoparticles adjuvants.
Author(s): GASPAR, E. B.; SANTOS, L. R.; ARAÚJO, F. R.; GULIAS-GOMES, C. C.; LINCOPAN, N.; BRANDÃO, H. M.; ROSINHA, G. M. S.
Publication year: 2012
Types of publication: Abstract in annals or event proceedings
Keywords: Vacina
Observation
Some of Embrapa's publications are published as ePub files. To read them, use or download one of the following free software options to your computer or mobile device. Android: Google Play Books; IOS: iBooks; Windows and Linux: Calibre.
Access other publications
Access the Agricultural Research Database (BDPA) to consult Embrapa's full library collection and records.
Visit Embrapa Bookstore to purchase books and other publications sold by Embrapa.